PODD - INSULET CORP

QQQ $ 445.88 $ 2.85 (0.64 %)

DIA $ 395.58 $ 1.12 (0.28 %)

SPY $ 523.16 $ 2.39 (0.46 %)

TLT $ 90.86 $ 0.51 (0.56 %)

GLD $ 218.12 $ 1.83 (0.85 %)

Previous Close

$ 172.27

Open

$ 169.33

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 167.99 - $ 172.79

52 Week Range

$ 125.82 - $ 331.65

Volume

2,319,853

Average Volume

Market Cap

12.7B

Beta (5Y Monthly)

$ 1.11

PE Ratio (TTM)

$ 54.29

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-23-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-05-2023	03-31-2023	10-Q
6	02-24-2023	12-31-2022	10-K
7	11-04-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-23-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-05-2020	09-30-2020	10-Q
16	08-07-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	02-26-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-03-2019	03-31-2019	10-Q
22	02-26-2019	12-31-2018	10-K
23	11-02-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-04-2018	03-31-2018	10-Q
26	02-22-2018	12-31-2017	10-K
27	11-03-2017	09-30-2017	10-Q
28	08-04-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	02-28-2017	12-31-2016	10-K
31	11-04-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	04-29-2016	03-31-2016	10-Q
34	02-29-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q
36	08-12-2015	06-30-2015	10-Q
37	04-30-2015	03-31-2015	10-Q
38	02-26-2015	12-31-2014	10-K
39	11-05-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

will-insulets-monopoly-crumble-appellate-court-ruling-signals-shift-in-automated-insulin-delivery-systems-market

Will Insulet's Monopoly Crumble? Appellate...
05/14/2024 18:44:39

Latest on Insulet and its legal battle with EOFlow. Understand the impact of the appellate court's decision on market dynam...

wall-street-trades-flat-on-mixed-producer-inflation-meme-stocks-see-wild-ride-bitcoin-drops-whats-driving-markets-tuesday

Wall Street Trades Flat On Mixed Producer ...
05/14/2024 17:58:56

Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York.

zer0es.tv Previews Video On X Saying "Sore...
05/14/2024 13:47:09

https://twitter.com/zer0estv/status/1790377825595216332

Barclays Maintains Equal-Weight on Insulet...
05/13/2024 18:04:12

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and lowers the price target from $213 to $200.

Canaccord Genuity Maintains Buy on Insulet...
05/10/2024 18:44:47

Canaccord Genuity analyst Kyle Rose maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $226 to $234.

stocks-pause-on-dismal-consumer-confidence-yields-dollar-rise-as-inflation-expectations-kick-higher-bitcoin-sinks-whats-driving-markets-friday-corrected

Stocks Pause On Dismal Consumer Confidence...
05/10/2024 17:28:26

Editor’s note: This story has been updated to correct an error in the price action of Charter Communications stock.

Raymond James Maintains Outperform on Insu...
05/10/2024 17:03:59

Raymond James analyst Jayson Bedford maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $218...

Jefferies Maintains Buy on Insulet, Raises...
05/10/2024 13:18:22

Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $255 to $260.

Insulet Expects Q2 Revenue Growth Of 15%-1...
05/09/2024 20:13:05

2024 Outlook:Revenue Guidance (in constant currency):For the year ending December 31, 2024, the Company is raising its expected...

Insulet Q1 Adj $0.73 Beats $0.39 Estimate,...
05/09/2024 20:03:17

Insulet (NASDAQ:PODD) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.39 by 87.1...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
05/09/2024 17:35:23

4 Analysts Assess Insulet: What You Need T...
05/07/2024 13:00:14

Wolfe Research Upgrades Insulet to Outperf...
05/07/2024 09:37:09

Wolfe Research analyst Mike Polark upgrades Insulet (NASDAQ:PODD) from Peer Perform to Outperform and announces $200 price t...

Insulet Announced That Ana Maria Chadwick ...
03/20/2024 10:01:03

Insulet Says Randomized Controlled Trial (...
03/08/2024 11:02:09

Insulet To Present Results From First Omni...
03/05/2024 11:04:08

top-stocks-not-named-nvidia-you-need-to-know-about-in-2024-heres-what-investors-think-about-them-wall-street-vs-reddit

Top Stocks Not Named Nvidia You Need To Kn...
02/29/2024 21:57:48

Nvidia Corp. is one of the leading top stocks with 60% gain in 2024, but other lesser-known names have outperformed.

On Thursday February 22, Insulet Gave Q1 2...
02/26/2024 20:20:09

2024 Outlook:Revenue Guidance (in constant currency):Guidance for the first quarter and full year 2024 reflects an estimated $2...

surgery-partners-posts-weak-sales-joins-kosmos-energy-moderna-and-other-big-stocks-moving-lower-on-monday

Surgery Partners Posts Weak Sales, Joins K...
02/26/2024 16:18:56

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, I...

Barclays Maintains Equal-Weight on Insulet...
02/26/2024 12:06:38

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and lowers the price target from $214 to $213.